Clinical Pharmacy Specialist – Acute Care Medical Oncology
The Johns Hopkins Hospital
The Clinical Pharmacy Specialist will be responsible for the provision and oversight of pharmacotherapy for patients on the acute care medical oncology service. The specialist will be one of three acute care medical oncology clinical pharmacy specialists who will together cover three medical oncology rounding teams, each with an average census of 10 to 14 patients.
The Clinical Pharmacy Specialist will be responsible for participating in multidisciplinary rounds. Responsibilities for the services will include assisting with pharmacy–related questions and clinical issues, providing patient education with a focus on chemotherapy and discharge medications, and collaborating with clinical dietitians to order and monitor parenteral nutrition. They will also work collaboratively with pharmacy team members for secondary coverage of the acute care gynecologic oncology service, which is managed by surgeons, gynecologic oncology fellows, and advanced practitioners. In addition to these responsibilities, the specialist will rotate coverage of the following services with other counterparts within the acute care oncology pharmacy specialist team: antimicrobial approval coverage, emergency (code/RRT) response, chemotherapy order assistance in non-oncology areas, and cross-coverage needs for acute care medical oncology, myeloid, lymphoid, or cellular therapy services.
The Clinical Pharmacy Specialist will also provide education to students, residents, pharmacists, and other health care practitioners and serve as a preceptor for pharmacy students and pharmacy residents of ASHP-accredited PGY-1 and PGY-2 pharmacy practice and specialty practice programs. Additionally, the Clinical Pharmacy Specialist will support drug research conducted by the institution and participate as an active member of hospital and departmental committees to assist with formulary management and policy development.
Preferred qualifications for this position include the completion of a PharmD degree, PGY-1 residency, and PGY-2 specialty residency in oncology with experience in solid tumor malignancies. Board of Pharmacy Specialties (BPS) certification is required within two years of start date.
From the 1889 opening of The Johns Hopkins Hospital, to the opening of the School of Medicine four years later, there emerged the concept of combining research, teaching and patient care. This model, the first of its kind, would lead to a national and international reputation for excellence and discovery.Today, Johns Hopkins uses one overarching name—Johns Hopkins Medicine—to identify its entire medical enterprise. This $6.7 billion system unites the physicians and scientists of the Johns Hopkins University School of Medicine with the health professionals and facilities that make up the broad, integrated Johns Hopkins Health System.